Cosmetics News and Research

RSS

FDA authorizes first COVID-19 test to detect COVID-19, influenza A and B

Today, the U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both COVID-19 and influenza A and B (flu).

7 Dec 2020

Plasma treatment decreases movement of plasticizers from blood bags

Medical products such as blood bags and tubing are often made from soft PVC, a plastic that contains phthalate plasticizers, which are suspected to be harmful to human health.

4 Dec 2020

First PSMA-targeted PET imaging drug approved for men with prostate cancer

Today, the U.S. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) - the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.

1 Dec 2020

FDA issues guidance on use of dry heat to support reuse of certain respirators

Today, the U.S. Food and Drug Administration issued guidance on the use of dry heat to help support the single-user reuse of certain particulate filtering facepiece respirators (FFRs), such as N95 respirators, by health care personnel when there is a limited supply of respirators during the COVID-19 public health emergency.

25 Nov 2020

FDA expands approved indication for influenza treatment to include post-exposure prevention

Today, the U.S. Food and Drug Administration expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu.

23 Nov 2020

California law banning toxic chemicals in cosmetics will transform industry

A toxic chemical ban signed into law in California will change the composition of cosmetics, shampoos, hair straighteners and other personal care products used by consumers across the country, industry officials and activists say.

23 Nov 2020

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms [about 88 pounds]) with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19.

23 Nov 2020

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10 to discuss the request for emergency use authorization (EUA) of a COVID-19 vaccine from Pfizer, Inc. in partnership with BioNTech Manufacturing GmbH.

23 Nov 2020

FDA approves first COVID-19 diagnostic test for at-home use

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results.

18 Nov 2020

Study: Cannabidiol molecule contains more potent antioxidants

Nowadays, cannabidiol is a star component, not only in the world of cosmetics, but also in pharmaceutics and nutrition due to its antioxidant properties and its therapeutical potential.

17 Nov 2020

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).

17 Nov 2020

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

Today, the U.S. Food and Drug Administration permitted marketing of a new device intended for the temporary reduction of sleep disturbance related to nightmares in adults 22 years or older who suffer from nightmare disorder or have nightmares from post-traumatic stress disorder (PTSD).

8 Nov 2020

FDA releases final guidance to help identify and prevent insanitary conditions at compounders’ facilities

Protecting patients from exposure to poor quality compounded drugs is a fundamental part of the U.S. Food and Drug Administration's drug compounding program, and we are committed to protecting patients.

6 Nov 2020

Collaborative effort will enable efficient oversight to prevent illegal, harmful products from entering the U.S.

Recently, leadership from the U.S. Food and Drug Administration, the U.S. Customs and Border Protection, and the U.S. Immigration and Customs Enforcement, Homeland Security Investigations signed a Memorandum of Understanding to stop harmful products that pose a threat to public health and attempt to enter the U.S. through International Mail Facilities.

30 Oct 2020

Scientists use new approach to analyze millions of chemical-gene interactions

A University of Massachusetts Amherst environmental health scientist has used an unprecedented objective approach to identify which molecular mechanisms in mammals are the most sensitive to chemical exposures.

30 Oct 2020

FDA grants approval of nonprescription Sklice lotion to treat head lice infestations

Today, the U.S. Food and Drug Administration approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use through a process called a prescription (Rx)-to-OTC switch.

27 Oct 2020

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

22 Oct 2020

FDA reissues EUA for certain filtering face-piece respirators manufactured in China

Today, the U.S. Food and Drug Administration (FDA) reissued the Emergency Use Authorization (EUA) for certain filtering face-piece respirators (FFRs) that are manufactured in China and are not approved by the Centers for Disease Control and Prevention's (CDC) National Institute for Occupational Safety and Health (NIOSH).

16 Oct 2020

FDA warns women about the risks of using NSAIDs in the second half of pregnancy

The U.S. Food and Drug Administration announced today in a Drug Safety Communication that it is requiring labeling changes for nonsteroidal anti-inflammatory drugs (NSAIDs).

15 Oct 2020

FDA approves Regeneron antibody drug as first treatment for Ebola virus

Today, the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric patients.

14 Oct 2020

Cosmetics News and Research

FDA authorizes first COVID-19 test to detect COVID-19, influenza A and B

Plasma treatment decreases movement of plasticizers from blood bags

First PSMA-targeted PET imaging drug approved for men with prostate cancer

FDA issues guidance on use of dry heat to support reuse of certain respirators

FDA expands approved indication for influenza treatment to include post-exposure prevention

California law banning toxic chemicals in cosmetics will transform industry

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

FDA schedules meeting to discuss emergency use authorization of COVID-19 vaccine from Pfizer

FDA approves first COVID-19 diagnostic test for at-home use

Study: Cannabidiol molecule contains more potent antioxidants

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

FDA authorizes marketing of new device intended to provide temporary relief from sleep disturbances

FDA releases final guidance to help identify and prevent insanitary conditions at compounders’ facilities

Collaborative effort will enable efficient oversight to prevent illegal, harmful products from entering the U.S.

Scientists use new approach to analyze millions of chemical-gene interactions

FDA grants approval of nonprescription Sklice lotion to treat head lice infestations

First antiviral treatment for COVID-19 receives FDA approval

FDA reissues EUA for certain filtering face-piece respirators manufactured in China

FDA warns women about the risks of using NSAIDs in the second half of pregnancy

FDA approves Regeneron antibody drug as first treatment for Ebola virus

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News